Loading asset research
Q3 2026 earnings · Oct 21
BriaCell Therapeutics Corp. Common Shares
BCTXNasdaq · USD · StocksQuote as of · Exchange session not verified$4.28
+6.73%
Today
BCTX
Loading 1D prices…
Market cap
$37.1M
Volume
241.7K
52w high
$14.6852w low
$2.60Company profile
BriaCell Therapeutics Corp. Common Shares
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
WEST VANCOUVER, British Columbia, Canada, United States
Fiscal year end
0731
CIK
1610820
Session & valuation
Open$4.08
Previous close$4.01
Day high$4.43
Day low$3.99
30-day avg. volume460.8K
Outstanding shares8.7M
Diluted EPS-$5.73
Latest annual period
P/E (trailing)-0.75
P/E (forward)-10.95
Price / book1.29
Beta1.53
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ATNMActinium Pharmaceuticals Inc. (Delaware) Common Stock | $37.1M | $90K | -37652.22% | -$1.09 | +0.85% | Buy |
| MIRAMIRA Pharmaceuticals Inc. Common Stock | $37M | $0.00 | — | -$1.35 | -2.10% | Buy |
| NNVCNanoViricides Inc. Common Stock | $37.4M | $0.00 | — | -$0.31 | -4.64% | Buy |
| FLNAFilana Therapeutics Inc. Common Stock | $36.7M | $0.00 | — | -$1.88 | -11.49% | Buy |
| IMMPImmutep Limited American Depositary Shares | $38.1M | — | — | -$0.539 | -3.89% | Hold |